4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Exagen Inc. (XGN) operates in the Diagnostics & Research industry and is headquartered in Vista, United States with about 216 employees. Its market capitalization is roughly $112 million. In the fiscal year ended 2025-12-31, XGN reported $67M in revenue and ($20M) in net income.
Exagen Inc. designs, develops, and commercializes various testing products under the AVISE brand in the United States.
Interactive charts & full statements → Open the XGN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $67M | $56M | $52M | $46M | — |
| Gross Profit | $39M | $33M | $30M | $21M | — |
| Operating Income (EBIT) | ($14M) | ($14M) | ($23M) | ($40M) | — |
| Net Income | ($20M) | ($15M) | ($24M) | ($47M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $17M | $17M | $17M | $17M | $16M |
| Gross Profit | $10M | $9M | $10M | $10M | $9M |
| Operating Income (EBIT) | ($3M) | ($5M) | ($3M) | ($3M) | ($3M) |
| Net Income | ($4M) | ($5M) | ($7M) | ($4M) | ($4M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $58M | $45M | $57M | $86M | — |
| Total Liabilities | $41M | $35M | $34M | $44M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive XGN viewer.
About TickerBase · Data methodology & sources